Zobrazeno 1 - 10
of 19
pro vyhledávání: '"hematological malignancie"'
Autor:
Elena Carrara, Elisa Razzaboni, Anna Maria Azzini, Maria Elena De Rui, Mariana Nunes Pinho Guedes, Anna Gorska, Maddalena Giannella, Linda Bussini, Michele Bartoletti, Federica Arbizzani, Zaira R. Palacios‐Baena, Giulia Caponcello, Natalia Maldonado, Jesús Rodríguez‐Baño, Carlo Visco, Mauro Krampera, Evelina Tacconelli
Main aim of this systematic review is to quantify the risk and identify predictors of clinical evolution of SARS-CoV-2 in hematological patients compared to different control populations. Two independent reviewers screened the literature assessing cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55798cb439caea0db7bc2c9590e05333
https://api.elsevier.com/content/abstract/scopus_id/85140263790
https://api.elsevier.com/content/abstract/scopus_id/85140263790
Publikováno v:
Journal of experimentalclinical cancer research : CR. 41(1)
Cell division cycle 20 homologue (CDC20) is a well-known regulator of cell cycle, as it controls the correct segregation of chromosomes during mitosis. Many studies have focused on the biological role of CDC20 in cancer development, as alterations of
Publikováno v:
Nuclear Oncology ISBN: 9783319260679
Nuclear Oncology ISBN: 9783031054938
Nuclear Oncology ISBN: 9783031054938
Monoclonal antibodies (MAbs) raised against cancer antigens may mediate antibody-dependent cell-mediated cytotoxicity. This form of cancer control arises from cytolysis of a target cell by effector lymphocytes, such as cytotoxic T lymphocytes or natu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66fe6ed245d99db92bbfddfcd4f61dba
https://doi.org/10.1007/978-3-319-26067-9_48-2
https://doi.org/10.1007/978-3-319-26067-9_48-2
Autor:
Zappasodi P, Cattaneo C, Ferretti V, Mina R, Ferreri AJ, Merli F, Oberti M, Krampera M, Romano A, Zerbi C, Ferrari J, Cavo M, Marco Salvini M, Bertù L, Fracchiolla N, Marchesi F, Massaia M, Marasco V, Cairoli R, Scattolin AM, Vannucchi AM, Gambacorti-Passerini C, Musto P, Gherlinzoni F, Cuneo A, Pinto A, Trentin L, Bocchia M, Galimberti, Coviello E, Morotti A, Falini B, Turrin M, Tafuri A, Billio A, Gentile M, Lemoli M, Venditti A, Della Porta M, Lanza F, Rigacci L, Tosi P, Mohamed S, Corso A, Luppi M, Giuliani N, Busca A, Pagano L, Bruno R, Grossi P, Corradini P, Passamonti F, Arcaini L.
The impact of secondary infections (SI) on COVID-19 outcome in patients with hematological malignancies (HM) is scarcely documented. To evaluate incidence, clinical characteristics, and outcome of SI, we analyzed the microbiologically documented SI i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32afc2278183e70a9c3713faa67f5c4f
https://hdl.handle.net/10807/223853
https://hdl.handle.net/10807/223853
Autor:
Alberto M. Martelli, Francesca Paganelli, Camilla Evangelisti, Francesca Chiarini, James A. McCubrey
Glycogen synthase kinase-3 (GSK-3) is an evolutionarily conserved, ubiquitously expressed, multifunctional serine/threonine protein kinase involved in the regulation of a variety of physiological processes. GSK-3 comprises two isoforms (α and β) wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::041c839ec9f8b82ef7334af2d13779e2
https://hdl.handle.net/11380/1291846
https://hdl.handle.net/11380/1291846
Autor:
Martina Sollini, Federica Scalorbi, Gayane Aghakhanyan, Sara Galimberti, Roberto Boni, Francesco Bartoli, Paola A. Erba
Publikováno v:
Nuclear Oncology ISBN: 9783319260679
Leukemias are a group of acute and chronic hematological neoplasias characterized by the dissemination of cancer cells originating in the bone marrow via the bloodstream. In 2016, the estimated number of new leukemia cases was more than 110,000 in al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e227671a54cc1b0c661073c6ef270e4
https://hdl.handle.net/10281/424700
https://hdl.handle.net/10281/424700
Publikováno v:
Терапевтический архив, Vol 80, Iss 7, Pp 38-43 (2008)
Aim. To detect risk factors (RF) to develop somatogenic psychoses (SP) in blood diseases. Material and methods. A total of 107 SP patients were examined with the disease corresponding to diagnostic points F05 or F06 (IDC-10). Results. The following R
Externí odkaz:
https://doaj.org/article/d02e5c148e1740d7b5ba3ee42be5a1d0
Autor:
Silvia Renica, Andrea Gori, Giovanna Travi, Chiara Vismara, Alessandra Bandera, Valeria Cento, Luna Colagrossi, Jacopo Colombo, Antonio Muscatello, Marta Vecchi, Claudia Alteri, Silvia Nerini Molteni, Maria Antonello, Vittorio Scaravilli, Elisa Matarazzo, Marco Merli, Diana Fanti, Emanuele Cattaneo, Carlo Federico Perno, Massimo Puoti, Giacomo Grasselli
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated with worse COVID-19 outcome. However, whether specific population can be at higher risk of viremia are to date unexplored. Methods This cross-sectional proof-of-concep
Autor:
Pierpaolo Correale, Andrea Ghelli Luserna di Rorà, Francesco Conforti, Gaetanina Golino, Caterina Riillo, Andrea Biondi, Massimo Martino, Giada Juli, Francesca Scionti, Pierfrancesco Tassone, Daniele Caracciolo, Emanuela Altomare, Gabriella Talarico, Eugénie Duroyon, Beatrice Belmonte, Nicoletta Polerà, Ludovic Lhermitte, Chiara Buracchi, Marco Rossi, Vahid Asnafi, Andrea Ballerini, Katia Grillone, Simona Sestito, Markus Hildinger, Greta Alampi, Cirino Botta, Maria Eugenia Gallo Cantafio, Maria Teresa Di Martino, Anna Maria Ferrari, Antonio Giordano, Mariamena Arbitrio, Pierosandro Tagliaferri, Licia Pensabene, Alessandro Gulino, Daniela Concolino, Giovanni Martinelli, Michelangelo Iannone, Claudio Tripodo, Giuseppe Gaipa
Publikováno v:
Journal for ImmunoTherapy of Cancer 9 (2021). doi:10.1136/jitc-2020-002026
info:cnr-pdr/source/autori:Caracciolo D; Riillo C; Ballerini A; Gaipa G; Lhermitte L; Rossi M; Botta C; Duroyon E; Grillone K; Cantafio M E G; Buracchi C; Alampi G; Gulino A; Belmonte B; Conforti F; Golino G; Juli G; Altomare E; Polera N; Scionti F; Arbitrio M; Iannone M; Martino M; Correale P; Talarico G; Di Rora A G L; Ferrari A; Concolino D; Sestito S; Pensabene L; Giordano A; Hildinger M; Di Martino M T; Martinelli G; Tripodo C; Asnafi V; Biondi A; Tagliaferri P; Tassone P;/titolo:Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia/doi:10.1136%2Fjitc-2020-002026/rivista:Journal for ImmunoTherapy of Cancer/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume:9
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
Journal for Immunotherapy of Cancer
info:cnr-pdr/source/autori:Caracciolo D; Riillo C; Ballerini A; Gaipa G; Lhermitte L; Rossi M; Botta C; Duroyon E; Grillone K; Cantafio M E G; Buracchi C; Alampi G; Gulino A; Belmonte B; Conforti F; Golino G; Juli G; Altomare E; Polera N; Scionti F; Arbitrio M; Iannone M; Martino M; Correale P; Talarico G; Di Rora A G L; Ferrari A; Concolino D; Sestito S; Pensabene L; Giordano A; Hildinger M; Di Martino M T; Martinelli G; Tripodo C; Asnafi V; Biondi A; Tagliaferri P; Tassone P;/titolo:Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia/doi:10.1136%2Fjitc-2020-002026/rivista:Journal for ImmunoTherapy of Cancer/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume:9
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
Journal for Immunotherapy of Cancer
BackgroundT-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease with a poor cure rate for relapsed/resistant patients. Due to the lack of T-cell restricted targetable antigens, effective immune-therapeutics are not presently available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eeb1321efaff0e422cc466351a69ebe
Autor:
Cristina Marrocchio, Elisa Baratella, Paola Crivelli, Maurizio Conti, Stefano Zedda, Maria Assunta Cova
Publikováno v:
Current Radiology Reports. 8
Purpose of Review: This paper is aimed at describing the main malignant hematolymphoid disorders and their most frequent imaging appearance. Recent Findings: Hematological malignancies are a heterogeneous group of neoplasms, including leukemia, lymph